Management minimal residual malignancy in man
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Oxford
Pergamon Pr.
1988
|
| Ausgabe: | 1. ed. |
| Schriftenreihe: | Medical oncology and tumor pharmacotherapy / Supplement
1 |
| Schlagworte: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV002421744 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t| | ||
| 008 | 891016s1988 xx |||| 00||| eng d | ||
| 020 | |a 0080361544 |9 0-08-036154-4 | ||
| 035 | |a (OCoLC)20895090 | ||
| 035 | |a (DE-599)BVBBV002421744 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 | ||
| 050 | 0 | |a RC270.8 | |
| 080 | |a 616-006.6-08 | ||
| 082 | 0 | |a 616.99/406 |2 19 | |
| 245 | 1 | 0 | |a Management minimal residual malignancy in man |c ed. by P. Reizenstein ... |
| 250 | |a 1. ed. | ||
| 264 | 1 | |a Oxford |b Pergamon Pr. |c 1988 | |
| 300 | |a 102 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Medical oncology and tumor pharmacotherapy / Supplement |v 1 | |
| 650 | 4 | |a Cancer |x Patients |x Medical care | |
| 650 | 4 | |a Neoplasms |x therapy | |
| 650 | 4 | |a Tumor Markers, Biological | |
| 650 | 4 | |a Tumors |x Chemotherapy | |
| 650 | 0 | 7 | |a Rezidiv |0 (DE-588)4130100-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 0 | 1 | |a Rezidiv |0 (DE-588)4130100-6 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Reizenstein, Peter |e Sonstige |4 oth | |
| 810 | 2 | |a Supplement |t Medical oncology and tumor pharmacotherapy |v 1 |w (DE-604)BV001291436 |9 1 | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-001571792 | |
Datensatz im Suchindex
| _version_ | 1819227112980086784 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV002421744 |
| callnumber-first | R - Medicine |
| callnumber-label | RC270 |
| callnumber-raw | RC270.8 |
| callnumber-search | RC270.8 |
| callnumber-sort | RC 3270.8 |
| callnumber-subject | RC - Internal Medicine |
| ctrlnum | (OCoLC)20895090 (DE-599)BVBBV002421744 |
| dewey-full | 616.99/406 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/406 |
| dewey-search | 616.99/406 |
| dewey-sort | 3616.99 3406 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| edition | 1. ed. |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01456nam a2200445 cb4500</leader><controlfield tag="001">BV002421744</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">891016s1988 xx |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0080361544</subfield><subfield code="9">0-08-036154-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)20895090</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV002421744</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC270.8</subfield></datafield><datafield tag="080" ind1=" " ind2=" "><subfield code="a">616-006.6-08</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/406</subfield><subfield code="2">19</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Management minimal residual malignancy in man</subfield><subfield code="c">ed. by P. Reizenstein ...</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1. ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford</subfield><subfield code="b">Pergamon Pr.</subfield><subfield code="c">1988</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">102 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Medical oncology and tumor pharmacotherapy / Supplement</subfield><subfield code="v">1</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Patients</subfield><subfield code="x">Medical care</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tumor Markers, Biological</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tumors</subfield><subfield code="x">Chemotherapy</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Rezidiv</subfield><subfield code="0">(DE-588)4130100-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Rezidiv</subfield><subfield code="0">(DE-588)4130100-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Reizenstein, Peter</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="810" ind1="2" ind2=" "><subfield code="a">Supplement</subfield><subfield code="t">Medical oncology and tumor pharmacotherapy</subfield><subfield code="v">1</subfield><subfield code="w">(DE-604)BV001291436</subfield><subfield code="9">1</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-001571792</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV002421744 |
| illustrated | Not Illustrated |
| indexdate | 2024-12-23T10:36:09Z |
| institution | BVB |
| isbn | 0080361544 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-001571792 |
| oclc_num | 20895090 |
| open_access_boolean | |
| owner | DE-12 |
| owner_facet | DE-12 |
| physical | 102 S. |
| publishDate | 1988 |
| publishDateSearch | 1988 |
| publishDateSort | 1988 |
| publisher | Pergamon Pr. |
| record_format | marc |
| series2 | Medical oncology and tumor pharmacotherapy / Supplement |
| spelling | Management minimal residual malignancy in man ed. by P. Reizenstein ... 1. ed. Oxford Pergamon Pr. 1988 102 S. txt rdacontent n rdamedia nc rdacarrier Medical oncology and tumor pharmacotherapy / Supplement 1 Cancer Patients Medical care Neoplasms therapy Tumor Markers, Biological Tumors Chemotherapy Rezidiv (DE-588)4130100-6 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Krebs Medizin (DE-588)4073781-0 s Rezidiv (DE-588)4130100-6 s DE-604 Reizenstein, Peter Sonstige oth Supplement Medical oncology and tumor pharmacotherapy 1 (DE-604)BV001291436 1 |
| spellingShingle | Management minimal residual malignancy in man Cancer Patients Medical care Neoplasms therapy Tumor Markers, Biological Tumors Chemotherapy Rezidiv (DE-588)4130100-6 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| subject_GND | (DE-588)4130100-6 (DE-588)4073781-0 (DE-588)4143413-4 |
| title | Management minimal residual malignancy in man |
| title_auth | Management minimal residual malignancy in man |
| title_exact_search | Management minimal residual malignancy in man |
| title_full | Management minimal residual malignancy in man ed. by P. Reizenstein ... |
| title_fullStr | Management minimal residual malignancy in man ed. by P. Reizenstein ... |
| title_full_unstemmed | Management minimal residual malignancy in man ed. by P. Reizenstein ... |
| title_short | Management minimal residual malignancy in man |
| title_sort | management minimal residual malignancy in man |
| topic | Cancer Patients Medical care Neoplasms therapy Tumor Markers, Biological Tumors Chemotherapy Rezidiv (DE-588)4130100-6 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| topic_facet | Cancer Patients Medical care Neoplasms therapy Tumor Markers, Biological Tumors Chemotherapy Rezidiv Krebs Medizin Aufsatzsammlung |
| volume_link | (DE-604)BV001291436 |
| work_keys_str_mv | AT reizensteinpeter managementminimalresidualmalignancyinman |